Literature DB >> 23406575

Role of leptin signaling in the pathogenesis of angiotensin II-mediated atrial fibrosis and fibrillation.

Akira Fukui1, Naohiko Takahashi, Chisato Nakada, Takayuki Masaki, Osamu Kume, Tetsuji Shinohara, Yasushi Teshima, Masahide Hara, Tetsunori Saikawa.   

Abstract

BACKGROUND: We examined the hypothesis that leptin signaling contributes to the atrial fibrosis and atrial fibrillation (AF) evoked by angiotensin II (AngII). METHODS AND
RESULTS: Eight-week-old male CL57/B6 (CNT) and leptin-deficient ob/ob mice (Ob) were subcutaneously infused with AngII (2.0 mg/kg per day). Two weeks later, transesophageal burst pacing and an electrophysiological study using isolated perfused hearts were performed. Left-atrial tissues were collected to determine interstitial fibrosis by Masson trichrome staining, and the expressions of mRNAs related to inflammatory profibrotic signals were assessed. Left-atrial fibroblasts were isolated from adult Sprague-Dawley and Zucker rats. The effects of leptin (100 ng/mL) or AngII (100 nmol/L) treatment were evaluated. In CNT-AngII mice, leptin expression in the left atrium was upregulated (P<0.01). Transesophageal burst pacing induced atrial fibrillation in 88% (7/8) of CNT-AngII mice, but not in Ob-AngII mice (0/8; P<0.01). In isolated perfused hearts, atrial fibrillation was induced only in CNT-AngII mice (4/6; 67%). Interatrial conduction time was prolonged in CNT-AngII mice (P<0.01), but not in Ob-AngII mice. The upregulation of collagen 1, collagen 3, transforming growth factor-β1, α-smooth muscle actin, MCP-1, F4/80, and RANTES mRNA, which was seen in CNT-AngII mice, was attenuated in Ob-AngII mice. In cultured Sprague-Dawley rat atrial fibroblasts, AngII treatment increased leptin expression (P<0.01). Addition of leptin increased transforming growth factor-β1, α-smooth muscle actin, MCP-1, and RANTES expressions in Sprague-Dawley rat atrial fibroblasts, but not in Zucker rat atrial fibroblasts.
CONCLUSIONS: Our results demonstrate for the first time that leptin signaling is essential for the development of atrial fibrosis and atrial fibrillation evoked by AngII.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23406575     DOI: 10.1161/CIRCEP.111.000104

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  26 in total

1.  Impaired sinoatrial node function and increased susceptibility to atrial fibrillation in mice lacking natriuretic peptide receptor C.

Authors:  Emmanuel E Egom; Kimberly Vella; Rui Hua; Hailey J Jansen; Motahareh Moghtadaei; Iuliia Polina; Oleg Bogachev; Rhea Hurnik; Martin Mackasey; Sara Rafferty; Gibanananda Ray; Robert A Rose
Journal:  J Physiol       Date:  2015-01-12       Impact factor: 5.182

2.  Telmisartan improves myocardial remodeling by inhibiting leptin autocrine activity and activating PPARγ.

Authors:  Hui Chen; Min Li; Lei Liu; Danjun Zhu; Gang Tian
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-19

Review 3.  Inflammation, a link between obesity and atrial fibrillation.

Authors:  Alina Scridon; Dan Dobreanu; Philippe Chevalier; Răzvan Constantin Şerban
Journal:  Inflamm Res       Date:  2015-05-01       Impact factor: 4.575

4.  Extreme Obesity is Associated with Low Success Rate of Atrial Fibrillation Catheter Ablation.

Authors:  Toshimasa Okabe; Benjamin Buck; Samuel A Hayes; Thura T Harfi; Muhammad R Afzal; Jaret Tyler; Mahmoud Houmsse; Steven J Kalbfleisch; Raul Weiss; John D Hummel; Ralph S Augostini; Emile G Daoud
Journal:  J Atr Fibrillation       Date:  2020-04-30

5.  Optimizing transesophageal atrial pacing in mice to detect atrial fibrillation.

Authors:  Matthew B Murphy; Kyungsoo Kim; Prince J Kannankeril; Tuerdi Subati; Joseph C Van Amburg; Joey V Barnett; Katherine T Murray
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-11-12       Impact factor: 4.733

Review 6.  Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities.

Authors:  Ilaria Russo; Nikolaos G Frangogiannis
Journal:  J Mol Cell Cardiol       Date:  2015-12-15       Impact factor: 5.000

Review 7.  Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities.

Authors:  Michele Cavalera; Junhong Wang; Nikolaos G Frangogiannis
Journal:  Transl Res       Date:  2014-05-10       Impact factor: 7.012

Review 8.  Biomarkers of Metabolic Syndrome: Role in Pathogenesis and Pathophysiology Of Atrial Fibrillation.

Authors:  Saira Rafaqat; Saima Sharif; Mona Majeed; Shagufta Naz; Farkhanda Manzoor; Sana Rafaqat
Journal:  J Atr Fibrillation       Date:  2021-08-31

Review 9.  Natriuretic Peptide Clearance Receptor (NPR-C) Pathway as a Novel Therapeutic Target in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF).

Authors:  Emmanuel Eroume A Egom
Journal:  Front Physiol       Date:  2021-05-21       Impact factor: 4.566

10.  PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II by reducing TGF-β1/Smads pathway activation.

Authors:  Juan Hu; Jing-Jing Zhang; Li Li; Shan-Ling Wang; Hai-Tao Yang; Xian-Wei Fan; Lei-Ming Zhang; Guang-Ling Hu; Hai-Xia Fu; Wei-Feng Song; Li-Jie Yan; Jing-Jing Liu; Jin-Tao Wu; Bin Kong
Journal:  J Cell Mol Med       Date:  2021-06-15       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.